215 related articles for article (PubMed ID: 20480411)
21. Hypermethylation-mediated reduction of WWOX expression in intraductal papillary mucinous neoplasms of the pancreas.
Nakayama S; Semba S; Maeda N; Matsushita M; Kuroda Y; Yokozaki H
Br J Cancer; 2009 May; 100(9):1438-43. PubMed ID: 19352382
[TBL] [Abstract][Full Text] [Related]
22. TFPI-2 methylation predicts poor prognosis in non-small cell lung cancer.
Wu D; Xiong L; Wu S; Jiang M; Lian G; Wang M
Lung Cancer; 2012 Apr; 76(1):106-11. PubMed ID: 21983100
[TBL] [Abstract][Full Text] [Related]
23. Molecular characterization of chronic obstructive pulmonary disease-related non-small cell lung cancer through aberrant methylation and alterations of EGFR signaling.
Suzuki M; Wada H; Yoshino M; Tian L; Shigematsu H; Suzuki H; Alaa M; Tamura H; Fujiwara T; Nagato K; Motohashi S; Moriya Y; Hoshino H; Yoshida S; Shibuya K; Hiroshima K; Nakatani Y; Yoshino I
Ann Surg Oncol; 2010 Mar; 17(3):878-88. PubMed ID: 19841986
[TBL] [Abstract][Full Text] [Related]
24. Identification of the methylation of p14ARF promoter as a novel non-invasive biomarker for early detection of lung cancer.
Li L; Shen Y; Wang M; Tang D; Luo Y; Jiao W; Wang Z; Yang R; Tian K
Clin Transl Oncol; 2014 Jun; 16(6):581-9. PubMed ID: 24154929
[TBL] [Abstract][Full Text] [Related]
25. Association of O6-methylguanine-DNA methyltransferase (MGMT) promoter methylation with p53 mutation occurrence in non-small cell lung cancer with different histology, gender, and smoking status.
Wu JY; Wang J; Lai JC; Cheng YW; Yeh KT; Wu TC; Chen CY; Lee H
Ann Surg Oncol; 2008 Nov; 15(11):3272-7. PubMed ID: 18712569
[TBL] [Abstract][Full Text] [Related]
26. Hypermethylation of the GATA genes in lung cancer.
Guo M; Akiyama Y; House MG; Hooker CM; Heath E; Gabrielson E; Yang SC; Han Y; Baylin SB; Herman JG; Brock MV
Clin Cancer Res; 2004 Dec; 10(23):7917-24. PubMed ID: 15585625
[TBL] [Abstract][Full Text] [Related]
27. RASSF1A promoter methylation and Kras2 mutations in non small cell lung cancer.
Li J; Zhang Z; Dai Z; Popkie AP; Plass C; Morrison C; Wang Y; You M
Neoplasia; 2003; 5(4):362-6. PubMed ID: 14511407
[TBL] [Abstract][Full Text] [Related]
28. Alterations in novel candidate tumor suppressor genes, ING1 and ING2 in human lung cancer.
Okano T; Gemma A; Hosoya Y; Hosomi Y; Nara M; Kokubo Y; Yoshimura A; Shibuya M; Nagashima M; Harris CC; Kudoh S
Oncol Rep; 2006 Mar; 15(3):545-9. PubMed ID: 16465410
[TBL] [Abstract][Full Text] [Related]
29. Genetic alterations of the WWOX gene in breast cancer.
Ekizoglu S; Muslumanoglu M; Dalay N; Buyru N
Med Oncol; 2012 Sep; 29(3):1529-35. PubMed ID: 21983861
[TBL] [Abstract][Full Text] [Related]
30. Characterization of the tumor suppressor gene WWOX in primary human oral squamous cell carcinomas.
Pimenta FJ; Gomes DA; Perdigão PF; Barbosa AA; Romano-Silva MA; Gomez MV; Aldaz CM; De Marco L; Gomez RS
Int J Cancer; 2006 Mar; 118(5):1154-8. PubMed ID: 16152610
[TBL] [Abstract][Full Text] [Related]
31. Association between CpG island methylation of the WWOX gene and its expression in breast cancers.
Wang X; Chao L; Jin G; Ma G; Zang Y; Sun J
Tumour Biol; 2009; 30(1):8-14. PubMed ID: 19188760
[TBL] [Abstract][Full Text] [Related]
32. EGFR activating mutations detected by different PCR techniques in Caucasian NSCLC patients with CNS metastases: short report.
Kamila WK; Michał S; Paweł K; Paulina J; Tomasz K; Bożena J; Radosław M; Justyna S; Marek S; Trojanowski T; Janusz M; Joanna CW
Clin Exp Metastasis; 2013 Dec; 30(8):1063-71. PubMed ID: 23892415
[TBL] [Abstract][Full Text] [Related]
33. Epigenetic modulation of endogenous tumor suppressor expression in lung cancer xenografts suppresses tumorigenicity.
Cantor JP; Iliopoulos D; Rao AS; Druck T; Semba S; Han SY; McCorkell KA; Lakshman TV; Collins JE; Wachsberger P; Friedberg JS; Huebner K
Int J Cancer; 2007 Jan; 120(1):24-31. PubMed ID: 17019711
[TBL] [Abstract][Full Text] [Related]
34. Association of downregulation of WWOX with poor prognosis in patients with intrahepatic cholangiocarcinoma after curative resection.
Huang C; Tian Y; Peng R; Zhang C; Wang D; Han S; Jiao C; Wang X; Zhang H; Wang Y; Li X
J Gastroenterol Hepatol; 2015 Feb; 30(2):421-33. PubMed ID: 25168293
[TBL] [Abstract][Full Text] [Related]
35. Multiple gene methylation of nonsmall cell lung cancers evaluated with 3-dimensional microarray.
Wang Y; Zhang D; Zheng W; Luo J; Bai Y; Lu Z
Cancer; 2008 Mar; 112(6):1325-36. PubMed ID: 18286531
[TBL] [Abstract][Full Text] [Related]
36. Pharmacologic inhibition of epigenetic modifications, coupled with gene expression profiling, reveals novel targets of aberrant DNA methylation and histone deacetylation in lung cancer.
Zhong S; Fields CR; Su N; Pan YX; Robertson KD
Oncogene; 2007 Apr; 26(18):2621-34. PubMed ID: 17043644
[TBL] [Abstract][Full Text] [Related]
37. Impact of WWOX alterations on p73, ΔNp73, p53, cell proliferation and DNA ploidy in salivary gland neoplasms.
Gomes CC; Diniz MG; Oliveira CS; Tavassoli M; Odell EW; Gomez RS; De Marco L
Oral Dis; 2011 Sep; 17(6):564-71. PubMed ID: 21332605
[TBL] [Abstract][Full Text] [Related]
38. Up-Regulation of miR-21 Expression Predicate Advanced Clinicopathological Features and Poor Prognosis in Patients with Non-Small Cell Lung Cancer.
Tian L; Shan W; Zhang Y; Lv X; Li X; Wei C
Pathol Oncol Res; 2016 Jan; 22(1):161-7. PubMed ID: 26453197
[TBL] [Abstract][Full Text] [Related]
39. Molecular spectrum of somatic EGFR and KRAS gene mutations in non small cell lung carcinoma: determination of frequency, distribution pattern and identification of novel variations in Indian patients.
Das BR; Bhaumik S; Ahmad F; Mandsaurwala A; Satam H
Pathol Oncol Res; 2015 Jul; 21(3):675-87. PubMed ID: 25637496
[TBL] [Abstract][Full Text] [Related]
40. Loss of WW domain-containing oxidoreductase expression in the progression and development of gastric carcinoma: clinical and histopathologic correlations.
Maeda N; Semba S; Nakayama S; Yanagihara K; Yokozaki H
Virchows Arch; 2010 Oct; 457(4):423-32. PubMed ID: 20737170
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]